Tumor Targeting by Peptide-Decorated Gold Nanoparticles

Autor: Véronique Mathieu, Andrea Temperini, Barbara Albertini, Silvio M L Greco, Paolo Blasi, Maurizio Ricci, Aurelie Marie Madeleine Schoubben, Nunzio Iraci, Nathalie Wauthoz, Matthias Van Woensel, Anna Donnadio
Přispěvatelé: Albertini B., Mathieu V., Iraci N., Van Woensel M., Schoubben A., Donnadio A., Greco S.M.L., Ricci M., Temperini A., Blasi P., Wauthoz N.
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Drug
glioblastoma
melanoma
nanomedicine
RGD-like peptide
αvβ3 integrin

media_common.quotation_subject
Integrin
Metal Nanoparticles
Pharmaceutical Science
Antineoplastic Agents
RGD-like peptide
02 engineering and technology
Blood–brain barrier
030226 pharmacology & pharmacy
Polyethylene Glycols
Mice
03 medical and health sciences
0302 clinical medicine
Breast cancer
Drug Discovery
medicine
melanoma
Animals
media_common
biology
Brain Neoplasms
Chemistry
Melanoma
αvβ3 integrin
glioblastoma
Cancer
Flow Cytometry
Integrin alphaVbeta3
021001 nanoscience & nanotechnology
medicine.disease
nanomedicine
Glioblastoma
Melanoma
Nanomedicine
RGD-like peptide
Avβ3 integrin
Animals
Antineoplastic Agents
Brain Neoplasms
Flow Cytometry
Glioblastoma
Gold
Integrin alphaVbeta3
Melanoma
Metal Nanoparticles
Mice
Nanomedicine
Polyethylene Glycols

medicine.anatomical_structure
Cancer research
biology.protein
Molecular Medicine
Nanomedicine
Sciences pharmaceutiques
Gold
Bone marrow
0210 nano-technology
Zdroj: Molecular pharmaceutics, 16 (6
Popis: Cancer remains one of the most important challenges in biomedical sciences. Chemotherapeutic agents are very potent molecules that exhibit a significant level of toxicity in numerous tissues of the body, particularly in those characterized by high proliferative activity, such as the bone marrow. The scenario is even more complex in the case of the central nervous system, and in particular brain tumors, where the blood brain barrier limits the efficacy of drug therapies. Integrins, transmembrane proteins widely expressed in different types of cancer (glioblastoma, melanoma, and breast cancer), regulate the angiogenic process and play a pivotal role in tumor growth and invasion. Here, we report a nanotechnology strategy based on the use of AuNPs decorated with an arginine-glycine-aspartic acid-like peptide for the diagnosis and treatment of cancer. Two hours after administration in mice, the accumulation of the peptide-decorated NPs in the subcutaneous tumor was ∼4-fold higher than that of uncoated particles and ∼1.4-fold higher than that of PEGylated particles. Also, in the case of the intracranial tumor model, interesting results were obtained. Indeed, 2 h after administration, the amount of peptide-decorated particles in the brain was 1.5-fold that of undecorated particles and 5-fold that of PEGylated particles. In conclusion, this preliminary study demonstrates the high potential of this carrier developed for diagnostic and therapeutic applications.
SCOPUS: ar.j
info:eu-repo/semantics/published
Databáze: OpenAIRE